Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women

Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection

(2020) Jennifer E Hibma et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis

(2020) Yohhei Hamada et al.   EUROPEAN RESPIRATORY JOURNAL

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

(2020) Kamunkhwala Gausi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine

(2020) David W. Haas et al.   Pharmacogenetics and Genomics

National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis

(2019) Hannah Blencowe et al.   Lancet Global Health

Brief Report

(2019) Sylvia M. LaCourse et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women

(2019) Amita Gupta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV

(2019) Mahmoud Tareq Abdelwahab et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data

(2019) Emma Kalk et al.   CLINICAL INFECTIOUS DISEASES

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

(2018) Kristina M Brooks et al.   CLINICAL INFECTIOUS DISEASES

Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa

(2015) Paolo Denti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of drugs in pregnancy

(2015) Maisa Feghali et al.   SEMINARS IN PERINATOLOGY

Treatment for Preventing Tuberculosis in Children and Adolescents

(2015) M. Elsa Villarino et al.   JAMA Pediatrics

Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and Bioavailability

(2014) Radojka M. Savic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tuberculosis in pregnancy: an estimate of the global burden of disease

(2014) Jordan Sugarman et al.   Lancet Global Health

Global causes of maternal death: a WHO systematic analysis

(2014) Lale Say et al.   Lancet Global Health

Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection

(2014) Marc Weiner et al.   Journal of the Pediatric Infectious Diseases Society

Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps

(2012) J. S. Mathad et al.   CLINICAL INFECTIOUS DISEASES

Risk of Tuberculosis in Pregnancy

(2011) Dominik Zenner et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Maternal Tuberculosis: A Risk Factor for Mother-to-Child Transmission of Human Immunodeficiency Virus

(2011) Amita Gupta et al.   JOURNAL OF INFECTIOUS DISEASES